New Johnson & Johnson CEO Plans Company’s Future
Johnson & Johnson’s incoming CEO plans to present himself as a “realistic optimist” when he addresses shareholders at the health care giant’s annual meeting Thursday.
Alex Gorsky, a J&J vice chairman who succeeds Bill Weldon later this month, says he’s optimistic the company can produce innovative medicines and other products. But Gorsky, 51, also will face challenges as he takes over the company that makes everything from “No More Tears” baby shampoo to Tylenol. It’s had mounting problems in recent years.
Those include about 30 product recalls due to quality lapses and a fine of more than $1.1 billion for downplaying and concealing the risks of its former blockbuster schizophrenia drug Risperdal.
(Copyright 2012 by The Associated Press. All Rights Reserved.)